全球医院获得性疾病检测市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

预计到 2032 年，全球医院获得性疾病检测市场的市场规模将从 2023 年的 200 万美元达到近 200 万美元，2024-2032 年研究期间复合年增长率为 15.13%。

医院获得性疾病检测涉及诊断医疗机构中因微生物感染或毒素而感染的疾病。重症监护室是医院中最常见的场所，任何人都可能患病，从而增加发病率、死亡率和医院费用。最常见的检验疾病包括手术部位感染、胃肠炎、肺炎、脑膜炎和泌尿道感染。这些疾病的主要原因是手、导管、呼吸器等医疗器材不干净，以及抗生素的过量或不当使用。这些疾病的检测仅透过视觉和症状进行诊断，可在入院 48 小时内、出院后 3 天或手术后 30 天内进行。

市场动态

医疗机构卫生条件差和抗药性微生物的出现将成为该市场成长的重要刺激因素。老年人口的增加和在医疗机构接受慢性病治疗的患者发病率的上升将促进该市场的成长。医疗保健行业的技术进步以及新颖的诊断技术和工具将有利于该市场的成长。更好的监测文化来检测定植患者中看不见的病原体并防止感染传播将是市场的助推器。缺乏预算、熟练劳动力和严格的政府法规将成为不利于市场成长的一些障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球医院获得性疾病检测市场的各个细分市场进行了包容性评估。医院获得性疾病检测行业的成长和趋势为这项研究提供了整体方法。

市场区隔

医院获得性疾病检测市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按测试类型

• 泌尿道
• 手术部位
• 肺炎
• 血流
• 抗甲氧西林金黄色葡萄球菌
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医院获得性疾病检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医院获得性疾病检测市场的主要参与者包括 Abbott Laboratories、Alere Inc、Becton、Dickinson And Company、BioMeRieux SA F、Hoffmann-La Roche Ltd、Hologic Inc、Siemens Healthcare、Diatherix Laboratories Inc.、Meridian Bioscience Inc.、ThermFisher Scientific Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：医院获得性疾病检测 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按测试类型进行的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球医院获得性疾病检测市场分析：按检测类型

• 按测试类型概述
• 历史和预测数据
• 按测试类型分析
• 泌尿道
• 手术部位
• 肺炎
• 血流
• 抗甲氧西林金黄色葡萄球菌
• 其他的

第 6 章：全球医院获得性疾病检测市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 7 章：医院获得性疾病检测公司的竞争格局

• 医院获得性疾病检测市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 8 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Abbott Laboratories
• 公司概况
• 公司收入
• 产品
• 最新动态
• Alere Inc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Becton
• 公司概况
• 公司收入
• 产品
• 最新动态
• Dickinson And Company
• 公司概况
• 公司收入
• 产品
• 最新动态
• BioMeRieux SA F
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hoffmann-La Roche Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hologic Inc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Siemens Healthcare
• 公司概况
• 公司收入
• 产品
• 最新动态
• Diatherix Laboratories Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Meridian Bioscience Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• ThermFisher Scientific Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Hospital Acquired Disease Testing Market is presumed to reach the market size of nearly USD XX.X Million by 2032 from USD XX.X Million in 2023 with a CAGR of 15.13% under the study period 2024-2032.

Hospital-acquired disease testing involves the diagnosis of diseases contracted from microbial infections or toxins in a healthcare facility. The intensive care unit is the most common location in a hospital where anyone can contract an illness, increasing morbidity, mortality, and hospital costs. The most common diseases tested include surgical site infections, gastroenteritis, pneumonia, meningitis, and urinary tract infections. The primary cause of these diseases is unclean hands, medical instruments such as catheters, respiratory machines, and excessive or improper use of antibiotics. The testing for these diseases involves diagnosis by sight and symptoms alone and can appear within 48 hours of admission, three days after discharge, or 30 days after an operation.

MARKET DYNAMICS

Lack of poor hygiene and the emergence of drug-resistant organisms in healthcare facilities will be the vital stimulating agents for this market's growth. Increasing the geriatric population and inflating morbidity rates among patients undergoing treatment for chronic diseases in a healthcare facility will boost this market's growth. Technological advancements in the healthcare industry and novel diagnostic techniques and tools will benefit this market's growth. Better surveillance cultures to detect unseen pathogens in colonized patients and prevent transmission of infections will be a market booster. The lack of budget, skilled labor and stringent government regulations will be a few hindrances not favorable to market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hospital Acquired Disease Testing. The growth and trends of Hospital Acquired Disease Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hospital Acquired Disease Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

• Urinary Tract
• Surgical Site
• Pneumonia
• Bloodstream
• MRSA
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hospital Acquired Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hospital Acquired Disease Testing market include Abbott Laboratories, Alere Inc, Becton, Dickinson And Company, BioMeRieux SA F, Hoffmann-La Roche Ltd, Hologic Inc, Siemens Healthcare, Diatherix Laboratories Inc., Meridian Bioscience Inc., ThermFisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HOSPITAL ACQUIRED DISEASE TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Test Type
  • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE

• 5.1. Overview By Test Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Test Type
• 5.4. Urinary Tract Historic and Forecast Sales By Regions
• 5.5. Surgical Site Historic and Forecast Sales By Regions
• 5.6. Pneumonia Historic and Forecast Sales By Regions
• 5.7. Bloodstream Historic and Forecast Sales By Regions
• 5.8. MRSA Historic and Forecast Sales By Regions
• 5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2 North America By Segment Sales Analysis
  • 6.3.3 North America By Country Sales Analysis
  • 6.3.4 United States Sales Analysis
  • 6.3.5 Canada Sales Analysis
  • 6.3.6 Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2 Europe By Segment Sales Analysis
  • 6.4.3 Europe By Country Sales Analysis
  • 6.4.4 United Kingdom Sales Analysis
  • 6.4.5 France Sales Analysis
  • 6.4.6 Germany Sales Analysis
  • 6.4.7 Italy Sales Analysis
  • 6.4.8 Russia Sales Analysis
  • 6.4.9 Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2 Asia Pacific By Segment Sales Analysis
  • 6.5.3 Asia Pacific By Country Sales Analysis
  • 6.5.4 China Sales Analysis
  • 6.5.5 India Sales Analysis
  • 6.5.6 Japan Sales Analysis
  • 6.5.7 South Korea Sales Analysis
  • 6.5.8 Australia Sales Analysis
  • 6.5.9 South East Asia Sales Analysis
  • 6.5.10 Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2 Latin America By Segment Sales Analysis
  • 6.6.3 Latin America By Country Sales Analysis
  • 6.6.4 Brazil Sales Analysis
  • 6.6.5 Argentina Sales Analysis
  • 6.6.6 Peru Sales Analysis
  • 6.6.7 Chile Sales Analysis
  • 6.6.8 Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2 Middle East & Africa By Segment Sales Analysis
  • 6.7.3 Middle East & Africa By Country Sales Analysis
  • 6.7.4 Saudi Arabia Sales Analysis
  • 6.7.5 UAE Sales Analysis
  • 6.7.6 Israel Sales Analysis
  • 6.7.7 South Africa Sales Analysis
  • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES

• 7.1. Hospital Acquired Disease Testing Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Abbott Laboratories
  • 8.3.1 Company Overview
  • 8.3.2 Company Revenue
  • 8.3.3 Products
  • 8.3.4 Recent Developments
• 8.4. Alere Inc
  • 8.4.1 Company Overview
  • 8.4.2 Company Revenue
  • 8.4.3 Products
  • 8.4.4 Recent Developments
• 8.5. Becton
  • 8.5.1 Company Overview
  • 8.5.2 Company Revenue
  • 8.5.3 Products
  • 8.5.4 Recent Developments
• 8.6. Dickinson And Company
  • 8.6.1 Company Overview
  • 8.6.2 Company Revenue
  • 8.6.3 Products
  • 8.6.4 Recent Developments
• 8.7. BioMeRieux SA F
  • 8.7.1 Company Overview
  • 8.7.2 Company Revenue
  • 8.7.3 Products
  • 8.7.4 Recent Developments
• 8.8. Hoffmann-La Roche Ltd
  • 8.8.1 Company Overview
  • 8.8.2 Company Revenue
  • 8.8.3 Products
  • 8.8.4 Recent Developments
• 8.9. Hologic Inc
  • 8.9.1 Company Overview
  • 8.9.2 Company Revenue
  • 8.9.3 Products
  • 8.9.4 Recent Developments
• 8.10. Siemens Healthcare
  • 8.10.1 Company Overview
  • 8.10.2 Company Revenue
  • 8.10.3 Products
  • 8.10.4 Recent Developments
• 8.11. Diatherix Laboratories Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Company Revenue
  • 8.11.3 Products
  • 8.11.4 Recent Developments
• 8.12. Meridian Bioscience Inc.
  • 8.12.1 Company Overview
  • 8.12.2 Company Revenue
  • 8.12.3 Products
  • 8.12.4 Recent Developments
• 8.13. ThermFisher Scientific Inc
  • 8.13.1 Company Overview
  • 8.13.2 Company Revenue
  • 8.13.3 Products
  • 8.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Test Type (USD MN)
• Urinary Tract Market Sales By Geography (USD MN)
• Surgical Site Market Sales By Geography (USD MN)
• Pneumonia Market Sales By Geography (USD MN)
• Bloodstream Market Sales By Geography (USD MN)
• MRSA Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Hospital Acquired Disease Testing Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Hospital Acquired Disease Testing Report
• Market Research Process
• Market Research Methodology
• Global Hospital Acquired Disease Testing Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Test Type
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Test Type (USD MN)
• Urinary Tract Market Sales By Geography (USD MN)
• Surgical Site Market Sales By Geography (USD MN)
• Pneumonia Market Sales By Geography (USD MN)
• Bloodstream Market Sales By Geography (USD MN)
• MRSA Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.